Universal Therapeutics partners DoctorOnCall for strategic distribution and administration of COVID-19 self-test kits in Malaysia

FOR IMMEDIATE RELEASE


Kuala Lumpur, Malaysia, 12 October 2021-- Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced its partnership with DoctorOnCall, Malaysia’s first and largest digital health platform. Consumers can now visit DoctorOnCall’s website and purchase COVID-19 self-test kits at a transparent, fixed price, and have the kits delivered to their homes.

 

The partnership addresses the prevalent issue of errant distribution and inconsistent price points of COVID-19 self-test kits in Malaysia. 

 

“Our focus has always been on providing safe and high-quality pharmaceutical and medical products to enhance people’s health and quality of life,” said Sidney Soares, Chief Executive Officer of Universal Therapeutics. “Being able to do so through responsible partners, such as DoctorOnCall, is extremely important to us, so as to ensure that our consumers and patients continue to receive the best care that they need.” 

 

“We resonate with Universal Therapeutics’ mission of providing safe and excellent medical products,” said Hazwan Najib, Co-Founder of DoctorOnCall Malaysia. “In fact, DoctorOnCall was founded to provide quality and affordable healthcare to Malaysians. We reduce waiting time at clinics and hospitals by shifting health consultations online. It is especially critical to provide this service now via a telehealth platform, considering the current pandemic. We are proud to be working with Universal Therapeutics to bring COVID-19 self-test kits to more consumers via our online platform, and look forward to continuing this strong partnership.”

 

Universal Therapeutics and DoctorOnCall are both committed to aiding the healthcare sector in Malaysia continue their battle against the COVID-19 virus.

 

###

 

For more information, please visit https://www.universal-therapeutics.com

 

About Universal Therapeutics:

Universal Therapeutics is a multinational pharmaceutical and biotech company based in Kuala Lumpur, Malaysia. The company’s businesses include manufacturing, distribution and white label production of pharmaceutical products, medical supplies, and PPEs in Asia and throughout the world.

 

Universal Therapeutics distributes Covid 19 Rapid Antigen tests to wholesalers, medical institutions, and government organisations. All our products comply with World Health Organization (WHO) guidelines and are accredited and approved by various health ministries as safe for human use. 

 

For more information, please contact:

Samuel CHAI

Group Chief Commercial Officer

Office: +60 3 9213 0318

Email: GroupPR@Universal-Therapeutics.com

Website: www.Universal-Therapeutics.com 

 

About DoctorOnCall

DoctorOnCall is Malaysia’s first and leading digital health platform with 2 million Malaysians visiting our website for telehealth consultation, online pharmacy, medication delivery, health content, doctors and specialist booking services. Since its establishment in 2016, DoctorOnCall has established partnerships with top insurers, third-party agencies, hospitals, pharmacies and corporations. These include Prudential, Zurich, Allianz, Great Eastern, Caring Pharmacy, TMC Life Sciences and Columbia Asia Hospitals amongst others.

For more information, visit us at https://www.doctoroncall.com.my/

For more information on the release:

Hazel Hassan

019 217 8191

hazel@hazel-ventures.com

 

Previous
Previous

Universal Therapeutics Diagnostics Sdn Bhd receives formal approval from Medical Device Authority (MDA), Malaysia our in-house manufacturing licence

Next
Next

Medical Device Authority approves TIB SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for Self-Test in Malaysia